CN1276219A - Medicine for treating hyperlipemia - Google Patents
Medicine for treating hyperlipemia Download PDFInfo
- Publication number
- CN1276219A CN1276219A CN 00107934 CN00107934A CN1276219A CN 1276219 A CN1276219 A CN 1276219A CN 00107934 CN00107934 CN 00107934 CN 00107934 A CN00107934 A CN 00107934A CN 1276219 A CN1276219 A CN 1276219A
- Authority
- CN
- China
- Prior art keywords
- milligrams
- rhizoma
- radix
- fructus
- medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
A medicine for treating hyperlipemia syndrome is disclosed. Its advantages are low cost, high curative effect and no by-effect.
Description
The present invention relates to a kind of medicine for the treatment of the hyperlipidemia syndrome.
At present the medicine of treatment hyperlipidemia mainly contains nicotinic acid, transfers the blood fat reducing pill, but drug price is than higher, and the course of treatment is long, particularly transfers the blood fat reducing pill can only fall at most about 10% patient's " triglyceride ", easily recurs after the drug withdrawal, and the patient has side effect to part.
The medicine that the purpose of this invention is to provide a kind of special curing hyperlipemia, this medicine all has tangible curative effect to the hyperlipidemia that various diseases causes, and instant effect, short treating period, non-relapse after healing, effective percentage can reach more than 98%, and cure rate can reach more than 90%.
The present invention adopts following principle to realize: the present invention adopts strong liver kidney tonifying, and blood circulation promoting and blood stasis dispelling is cleansed expectorant and stagnated, and the evanescence of heat of dispelling is wet, and enhancing body promotes the activity of lipase to the synthetic minimizing of fat, quickens the dissolving of lipoprotein, realizes the blood fat reducing purpose.
Below be detailed prescription of the present invention and processing technology: 30 milligrams of Rhizoma Chuanxiongs; 40 milligrams of Radix Salviae Miltiorrhizaes; 10 milligrams of the Rhizoma Atractylodis Macrocephalaes; 40 milligrams of Fructus Crataegis; 20 milligrams of Radix Angelicae Sinensis; 15 milligrams of Flos Chrysanthemis; 10 milligrams of Rhizoma Alismatis; 10 milligrams of Radix Notoginseng; 20 milligrams of Herba Ecliptaes; 15 milligrams of Stigma Maydis; 20 milligrams of Pheretimas; 10 milligrams of Calculus Boviss; 30 milligrams of Fructus Tribulis; 20 milligrams of Cordycepses; 20 milligrams of Radix Ophiopogonis; 20 milligrams of Rhizoma Dioscoreaes; 20 milligrams of Fructus Ligustri Lucidi; 30 milligrams of Caulis Polygoni Multiflori; 5 milligrams of Moschuss; 15 milligrams of Cornu Saigae Tataricae.
Processing technology: selected above medicine, clean, dry, be condensed into powder, per 0.4 gram capsule of packing into gets final product.The patient obeys the 4-6 grain at every turn, and every day three times, can cure 3-4 the course of treatment.
Claims (1)
1, a kind of medicine that cures mainly the hyperlipidemia syndrome, it by Rhizoma Chuanxiong, Radix Salviae Miltiorrhizae, the Rhizoma Atractylodis Macrocephalae, Fructus Crataegi, Radix Angelicae Sinensis, Flos Chrysanthemi, Rhizoma Alismatis, Radix Notoginseng, Herba Ecliptae, Stigma Maydis, Pheretima, Calculus Bovis, Fructus Tribuli, Cordyceps, Radix Ophiopogonis, Rhizoma Dioscoreae, Fructus Ligustri Lucidi, Caulis Polygoni Multiflori, Moschus, Cornu Saigae Tataricae, form, it is characterized in that mainly containing in the medicine: 30 milligrams of Rhizoma Chuanxiongs; 40 milligrams of Radix Salviae Miltiorrhizaes; 10 milligrams of the Rhizoma Atractylodis Macrocephalaes; 40 milligrams of Fructus Crataegis; 20 milligrams of Radix Angelicae Sinensis; 15 milligrams of Flos Chrysanthemis; 10 milligrams of Rhizoma Alismatis; 10 milligrams of Radix Notoginseng; 20 milligrams of Herba Ecliptaes; 15 milligrams of Stigma Maydis; 20 milligrams of Pheretimas; 10 milligrams of Calculus Boviss; 30 milligrams of Fructus Tribulis; 20 milligrams of Cordycepses; 20 milligrams of Radix Ophiopogonis; 20 milligrams of Rhizoma Dioscoreaes; 20 milligrams of Fructus Ligustri Lucidi, 30 milligrams of Caulis Polygoni Multiflori; 5 milligrams of Moschuss; 15 milligrams of Cornu Saigae Tataricae.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 00107934 CN1276219A (en) | 2000-05-31 | 2000-05-31 | Medicine for treating hyperlipemia |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 00107934 CN1276219A (en) | 2000-05-31 | 2000-05-31 | Medicine for treating hyperlipemia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1276219A true CN1276219A (en) | 2000-12-13 |
Family
ID=4579035
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 00107934 Pending CN1276219A (en) | 2000-05-31 | 2000-05-31 | Medicine for treating hyperlipemia |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1276219A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8747913B2 (en) | 2004-12-10 | 2014-06-10 | Tasly Pharmaceutical Group Co., Ltd | Herbal extract pharmaceutical composition and method for treating and/or preventing of hyperlipidemia and processes for producing the same |
-
2000
- 2000-05-31 CN CN 00107934 patent/CN1276219A/en active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8747913B2 (en) | 2004-12-10 | 2014-06-10 | Tasly Pharmaceutical Group Co., Ltd | Herbal extract pharmaceutical composition and method for treating and/or preventing of hyperlipidemia and processes for producing the same |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1076120A (en) | Medical liquid for relaxing tendons and joints | |
| CN1098700C (en) | Chinese patent medicine for treating piles | |
| CN1204523A (en) | Prescription of dispelling wind and strengthening bone wine and preparation method | |
| CN101028481A (en) | Medicinal liquor for treating hyperosteogeny and lumbar intervertebral disc protrusion | |
| CN1457831A (en) | Dynamic medicine for channels and collaterals and blood vessel | |
| CN1278446A (en) | Chinese medicinal composition for cerebrovascular disease, rheumatism and rheumatoid disease | |
| CN1150926C (en) | Medicine for treating hepatism | |
| CN1047083C (en) | Pill for curing pelade | |
| CN1057230C (en) | Traditional Chinese medicine capsule for treating thrombophlebitis | |
| CN1385191A (en) | Medicine for treating liver disease | |
| CN1331996A (en) | Hepatitis B treaitng pill | |
| CN1276219A (en) | Medicine for treating hyperlipemia | |
| CN1102399C (en) | Antilipemic blood circulation promoting xueluofu capsale | |
| CN1057912C (en) | "Danshenye" Chinese medicinal liquid for treatment of cholecystitis | |
| CN1051460C (en) | Medicine for treatment of leukoderma and its preparing method | |
| CN1212872A (en) | Chinese patent drug for treating psoriasis | |
| CN1562327A (en) | Decoction of turning negative in five steps for virus of hepatitis B | |
| CN102018909A (en) | Chinese medicinal preparation for treating ulcer of lower limb | |
| CN1058622C (en) | Rehabilitation powder for hepatitis B | |
| CN102038834A (en) | Traditional Chinese medicine preparation for preventing and treating cancers | |
| CN1054535C (en) | Kidney-reinforcing, channel-relaxing and wind evil-dispelling tonic wine | |
| CN105663679A (en) | Traditional Chinese medicine composition for treating ichthyosis | |
| CN104666630A (en) | Traditional Chinese medicine for treating prostatitis | |
| CN1456184A (en) | Appendicitis instant powdery preparation | |
| CN1129578A (en) | Formulation of Ganmaosuyusan for curing common cold |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |